Last reviewed · How we verify

Basophil Activation Test — Competitive Intelligence Brief

Basophil Activation Test (Basophil Activation Test) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Immunology/Allergy.

marketed Immunology/Allergy Biologic Live · refreshed every 30 min

Target snapshot

Basophil Activation Test (Basophil Activation Test) — University Hospital, Rouen. The Basophil Activation Test (BAT) is a flow cytometry-based diagnostic assay that measures basophil degranulation in response to allergen exposure to identify IgE-mediated allergic sensitization.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Basophil Activation Test TARGET Basophil Activation Test University Hospital, Rouen marketed

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Basophil Activation Test — Competitive Intelligence Brief. https://druglandscape.com/ci/basophil-activation-test. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: